Education
About Us
Working with TipRanks
Follow Us
COSMO Pharmaceuticals N.V. (DE:C43)
FRANKFURT:C43
Total Valuation
COSMO Pharmaceuticals N.V. has a market cap or net worth of €1.75B. The enterprise value is €1.56B.
Market Cap€1.75B
Enterprise Value€1.56B
Share Statistics
COSMO Pharmaceuticals N.V. has 17,543,522 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,543,522
Owned by Insiders―
Owned by Institutions0.05%
Financial Efficiency
COSMO Pharmaceuticals N.V.’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is -1.78%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)-1.78%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee326.65K
Profits Per Employee-11.31K
Employee Count321
Asset Turnover0.17
Inventory Turnover5.38
Valuation Ratios
The current PE Ratio of COSMO Pharmaceuticals N.V. is ―. COSMO Pharmaceuticals N.V.’s PEG ratio is 4.83.
PE Ratio―
PS Ratio17.21
PB Ratio3.74
Price to Fair Value3.74
Price to FCF-113.83
Price to Operating Cash Flow-135.05
PEG Ratio4.83
Income Statement
In the last 12 months, COSMO Pharmaceuticals N.V. had revenue of 104.85M and earned -3.63M in profits. Earnings per share was -0.23.
Revenue104.85M
Gross Profit48.78M
Operating Income-10.48M
Pretax Income-924.00K
Net Income-3.63M
EBITDA2.36M
Earnings Per Share (EPS)-0.23
Cash Flow
In the last 12 months, operating cash flow was -11.80M and capital expenditures -4.18M, giving a free cash flow of -15.99M billion.
Operating Cash Flow-11.80M
Free Cash Flow-15.99M
Free Cash Flow per Share-0.91
Dividends & Yields
COSMO Pharmaceuticals N.V. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change101.60%
50-Day Moving Average122.38
200-Day Moving Average84.19
Relative Strength Index (RSI)33.68
Average Volume (3m)48.00
Important Dates
COSMO Pharmaceuticals N.V. upcoming earnings date is Jul 29, 2026, Before Open (Confirmed).
Last Earnings DateMar 9, 2026
Next Earnings DateJul 29, 2026
Ex-Dividend Date―
Financial Position
COSMO Pharmaceuticals N.V. as a current ratio of 7.18, with Debt / Equity ratio of 0.88%
Current Ratio7.18
Quick Ratio6.77
Debt to Market Cap<0.01
Net Debt to EBITDA-21.88
Interest Coverage Ratio-57.54
Taxes
In the past 12 months, COSMO Pharmaceuticals N.V. has paid 2.59M in taxes.
Income Tax2.59M
Effective Tax Rate-2.80
Enterprise Valuation
COSMO Pharmaceuticals N.V. EV to EBITDA ratio is 743.79, with an EV/FCF ratio of -110.58.
EV to Sales16.71
EV to EBITDA743.79
EV to Free Cash Flow-110.58
EV to Operating Cash Flow-150.87
Balance Sheet
COSMO Pharmaceuticals N.V. has €122.66M in cash and marketable securities with €4.26M in debt, giving a net cash position of €118.40M billion.
Cash & Marketable Securities€122.66M
Total Debt€4.26M
Net Cash€118.40M
Net Cash Per Share€6.75
Tangible Book Value Per Share€8.72
Margins
Gross margin is 48.53%, with operating margin of -10.00%, and net profit margin of -3.46%.
Gross Margin48.53%
Operating Margin-10.00%
Pretax Margin-0.88%
Net Profit Margin-3.46%
EBITDA Margin2.25%
EBIT Margin-10.00%
Analyst Forecast
The average price target for COSMO Pharmaceuticals N.V. is €155.16, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€155.16
Price Target Upside43.66% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast―